Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
Classement en actions
#787
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
Prix de l'action
$25.47
Capitalisation boursière
$30.86B
Changement (1 jour)
3.53%
Changement (1 an)
-18.86%
Pays
CN
Échange Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
Catégorie
Healthcare
Bénéfices pour Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
Bénéfices en Jun 2026 TTM : $1.35B
Selon les derniers rapports financiers de Shenzhen Mindray Bio-Medical Electronics Co., Ltd., les bénéfices actuels de l'entreprise sont de $1.35B. En 2023, l'entreprise a réalisé un bénéfice de $1.84B, une augmentation par rapport à celui de 2022 qui était de $1.59B. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Shenzhen Mindray Bio-Medical Electronics Co., Ltd. de 2014 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $1.35B | -24.34% |
| 2024 | $1.78B | -2.96% |
| 2023 | $1.84B | 15.75% |
| 2022 | $1.59B | 11.93% |
| 2021 | $1.42B | 24.59% |
| 2020 | $1.14B | 47.70% |
| 2019 | $770.94M | 25.12% |
| 2018 | $616.16M | 36.76% |
| 2017 | $450.55M | 68.95% |
| 2016 | $266.68M | 58.95% |
| 2015 | $167.78M | -28.63% |
| 2014 | $235.08M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $7.51B | 456.53% |
US
|
|
| $5.56B | 312.19% |
IE
|
|
| $5.15B | 281.44% |
US
|
|
| $3.86B | 186.08% |
US
|
|
| - | - |
DE
|
